feed,title,long_url,short_url
🔐MarketWatch,"The Ratings Game: Activision stock looks undervalued with or without a Microsoft deal, says analyst",http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-715C-FE4F330C3A4D%7D&siteid=rss&rss=1,https://on.mktw.net/3VfGsbd
🔐MarketWatch,Metals Stocks: Gold prices flat as traders eye unrest in China,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-715D-01CE1E594B5B%7D&siteid=rss&rss=1,https://on.mktw.net/3UezJwQ
🔐MarketWatch,Beth Pinsker: This is what tax experts are telling clients who lost money on cryptocurrencies this year,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-715B-8DEC2F183FA0%7D&siteid=rss&rss=1,https://on.mktw.net/3F8VeLp
🔐MarketWatch,Stocks open lower as China protests rattle markets,http://www.marketwatch.com/news/story/stocks-open-lower-china-protests/story.aspx?guid=%7B5440F411%2DFF4A%2D412C%2DBAD6%2DA22438E50FC7%7D&siteid=rss,https://on.mktw.net/3Vx6oin
🔐MarketWatch,"DraftKings stock sinks after J.P. Morgan turns bearish, PENN Entertainment also downgraded",http://www.marketwatch.com/news/story/draftkings-stock-sinks-after-jp/story.aspx?guid=%7B446A7FCF%2DD0B6%2D4D07%2D8A3A%2D06694BDE0C9A%7D&siteid=rss,https://on.mktw.net/3OPcn00
🔐MarketWatch,CinCor's hypertension drug misses primary endpoint in mid-stage study,http://www.marketwatch.com/news/story/cincors-hypertension-drug-misses-primary/story.aspx?guid=%7BD9152D29%2DED86%2D4C8B%2DBE6D%2D6EDF33C17C12%7D&siteid=rss,https://on.mktw.net/3F9Yu9x
🔐MarketWatch,Sarepta expected to get FDA decision on Duchenne treatment by May 29,http://www.marketwatch.com/news/story/sarepta-expected-get-fda-decision/story.aspx?guid=%7BFF8F4859%2D6A77%2D4AC2%2D8372%2D2EA474FC4633%7D&siteid=rss,https://on.mktw.net/3GStmws
🔐MarketWatch,"Taboola stock rockets after 30-year agreement with Yahoo, making Yahoo the largest shareholder",http://www.marketwatch.com/news/story/taboola-stock-rockets-after-30-year/story.aspx?guid=%7BA9C924D2%2D2A37%2D4E96%2D8844%2D56D9C95D33AE%7D&siteid=rss,https://on.mktw.net/3VCMuml
🔐MarketWatch,Axsome's stock rallies 15% on promising findings for its experimental Alzheimer's drug,http://www.marketwatch.com/news/story/axsomes-stock-rallies-15-promising/story.aspx?guid=%7B0562B3CF%2D67EA%2D4D01%2D99FD%2D46BFBFBCAD65%7D&siteid=rss,https://on.mktw.net/3Uc7MG7
